Supported by the PIP Framework Partnership Contribution, in 2022, WHO initiated a project to estimate medical countermeasures (MCMs) needed during a future influenza pandemic. Effective planning for t...

The health system in Kenya has for the longest time been of great concern to many. A section of Kenyans have complained about poor services in hospitals where some have lost their loved ones due to al...

    News Release Ministers and representatives from twelve African countries have committed themselves, and laid out their plans, to end AIDS in children by 2030. International partners have...

A controlled substance is generally a drug or chemical whose manufacture, possession, or use is regulated by a government, such as illicitly used drugs or prescription medications that are designated ...

The Kenya demographic and health survey  2022 shows that the average number of sexual partners are 2:3 among women and 7:4 among men in Kenya. Background The primary objective of the 2022 Kenya Demog...

14 December 2022 / News release Urgent action is needed globally and locally to achieve safe and sustainably managed water, sanitation and hygiene for all in order to prevent devastating impacts on th...

7 December 2022 / News release / Geneva   Member States of the World Health Organization today agreed to develop the first draft of a legally binding agreement designed to protect the world from ...

WHO is launching a global scientific process to update the list of priority pathogens—agents that can cause outbreaks or pandemics—to guide global investment, research and development (R&D), e...

Meeting on the sidelines of the International Conference on Family Planning in Thailand, the World Health Organization (WHO), the UN Special Research Programme HRP, and FP2030 today signed a Memorandu...

On the eve of the pivotal climate talks at COP27, WHO issued a grim reminder that the climate crisis continues to make people sick and jeopardize lives, and that health must be at the core of these cr...

The Medicines Control Authority of Zimbabwe (MCAZ) announced that it has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention. “The ...

The World Health Organization (WHO) and the International Development Innovation Alliance (IDIA) have agreed to renew their strategic Collaborative Agreement to support the scaling of health innovatio...